Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360
Large-scale testing (Phase 3)Looking for participantsNCT06923475
What this trial is testing

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Who this might be right for
Extrahepatic CholangiocarcinomaPerihilar CholangiocarcinomaDistal Cholangiocarcinoma+2 more
Amsterdam UMC, location VUmc 150
Testing effectiveness (Phase 2)Study completedNCT04233567
What this trial is testing

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmCholangiocarcinomaMetastatic Malignant Solid Neoplasm+1 more
Sameek Roychowdhury 17
Large-scale testing (Phase 3)Not Yet RecruitingNCT07328919
What this trial is testing

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 138
Early research (Phase 1)Not Yet RecruitingNCT06490198
What this trial is testing

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

Who this might be right for
CholangiocarcinomaChemotherapy EffectImmunotherapy
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00030511
What this trial is testing

Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer

Who this might be right for
Extrahepatic Bile Duct CancerLiver Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Ended earlyNCT05501912
What this trial is testing

ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Shanghai Company Limited 20
Not applicableStudy completedNCT04871321
What this trial is testing

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
CHA University 119
Early research (Phase 1)Temporarily pausedNCT00624182
What this trial is testing

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Who this might be right for
Bile Duct Cancer
Akita University Hospital 9
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Testing effectiveness (Phase 2)Ended earlyNCT04099888
What this trial is testing

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Who this might be right for
Cholangiocarcinoma
PCI Biotech AS 41
Testing effectiveness (Phase 2)Ended earlyNCT04203160
What this trial is testing

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Very early researchWithdrawnNCT06284226
What this trial is testing

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Who this might be right for
Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)
Beijing Kejing Biotechnology Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT02609958
What this trial is testing

ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy

Who this might be right for
Cholangiocarcinoma
ASLAN Pharmaceuticals 32
Testing effectiveness (Phase 2)Looking for participantsNCT07841574
What this trial is testing

HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Lianghe Lu 35
Not applicableLooking for participantsNCT07640048
What this trial is testing

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Peking Union Medical College Hospital 90
Next Page